Literature DB >> 20707003

A well-characterised peak identification list of MALDI MS profile peaks for human blood serum.

Ali Tiss1, Celia Smith, Usha Menon, Ian Jacobs, John F Timms, Rainer Cramer.   

Abstract

MALDI MS profiling, using easily available body fluids such as blood serum, has attracted considerable interest for its potential in clinical applications. Despite the numerous reports on MALDI MS profiling of human serum, there is only scarce information on the identity of the species making up these profiles, particularly in the mass range of larger peptides. Here, we provide a list of more than 90 entries of MALDI MS profile peak identities up to 10 kDa obtained from human blood serum. Various modifications such as phosphorylation were detected among the peptide identifications. The overlap with the few other MALDI MS peak lists published so far was found to be limited and hence our list significantly extends the number of identified peaks commonly found in MALDI MS profiling of human blood serum.

Entities:  

Mesh:

Year:  2010        PMID: 20707003     DOI: 10.1002/pmic.201000100

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  13 in total

1.  Multifaceted Mass Spectrometric Investigation of Neuropeptide Changes in Atlantic Blue Crab, Callinectes sapidus, in Response to Low pH Stress.

Authors:  Yang Liu; Amanda R Buchberger; Kellen DeLaney; Zihui Li; Lingjun Li
Journal:  J Proteome Res       Date:  2019-06-10       Impact factor: 4.466

2.  Detection of pancreatic cancer using serum protein profiling.

Authors:  Berit Velstra; Bert A Bonsing; Bart J Mertens; Yuri E M van der Burgt; Anouck Huijbers; Hans Vasen; Wilma E Mesker; André M Deelder; Rob A E M Tollenaar
Journal:  HPB (Oxford)       Date:  2012-11-30       Impact factor: 3.647

3.  Multiplatform metabolome and proteome profiling identifies serum metabolite and protein signatures as prospective biomarkers for schizophrenia.

Authors:  Khaled Al Awam; Ida Sibylle Haußleiter; Ed Dudley; Rossen Donev; Martin Brüne; Georg Juckel; Johannes Thome
Journal:  J Neural Transm (Vienna)       Date:  2014-05-01       Impact factor: 3.575

4.  Serum peptide signatures for pancreatic cancer based on mass spectrometry: a comparison to CA19-9 levels and routine imaging techniques.

Authors:  Berit Velstra; Marieke A Vonk; Bert A Bonsing; Bart J Mertens; Simone Nicolardi; Anouck Huijbers; Hans Vasen; André M Deelder; Wilma E Mesker; Yuri E M van der Burgt; Rob A E M Tollenaar
Journal:  J Cancer Res Clin Oncol       Date:  2014-09-21       Impact factor: 4.553

5.  Improved classification of breast cancer peptide and protein profiles by combining two serum workup procedures.

Authors:  Berit Velstra; Yuri E M van der Burgt; Bart J Mertens; Wilma E Mesker; André M Deelder; Rob A E M Tollenaar
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-05       Impact factor: 4.553

6.  Biomarker discovery and redundancy reduction towards classification using a multi-factorial MALDI-TOF MS T2DM mouse model dataset.

Authors:  Chris Bauer; Frank Kleinjung; Celia J Smith; Mark W Towers; Ali Tiss; Alexandra Chadt; Tanja Dreja; Dieter Beule; Hadi Al-Hasani; Knut Reinert; Johannes Schuchhardt; Rainer Cramer
Journal:  BMC Bioinformatics       Date:  2011-05-09       Impact factor: 3.169

7.  Proteomic analysis of polypeptides captured from blood during extracorporeal albumin dialysis in patients with cholestasis and resistant pruritus.

Authors:  Marina Gay; Albert Pares; Montserrat Carrascal; Pau Bosch-i-Crespo; Marina Gorga; Antoni Mas; Joaquin Abian
Journal:  PLoS One       Date:  2011-07-14       Impact factor: 3.240

8.  Serum profiling by MALDI-TOF mass spectrometry as a diagnostic tool for domoic acid toxicosis in California sea lions.

Authors:  Benjamin A Neely; Jennifer L Soper; Denise J Greig; Kevin P Carlin; Elizabeth G Favre; Frances Md Gulland; Jonas S Almeida; Michael G Janech
Journal:  Proteome Sci       Date:  2012-03-19       Impact factor: 2.480

9.  Two classifiers based on serum peptide pattern for prediction of HBV-induced liver cirrhosis using MALDI-TOF MS.

Authors:  Yuan Cao; Kun He; Ming Cheng; Hai-Yan Si; He-Lin Zhang; Wei Song; Ai-Ling Li; Cheng-Jin Hu; Na Wang
Journal:  Biomed Res Int       Date:  2013-02-19       Impact factor: 3.411

10.  Identification of potential serum peptide biomarkers of biliary tract cancer using MALDI MS profiling.

Authors:  Neomal S Sandanayake; Stephane Camuzeaux; John Sinclair; Oleg Blyuss; Fausto Andreola; Michael H Chapman; George J Webster; Ross C Smith; John F Timms; Stephen P Pereira
Journal:  BMC Clin Pathol       Date:  2014-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.